Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2026-06-02 16:05:27 ET · period of report 2026-03-02 · accession 0001193125-26-253474 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-02 16:05 | 2026-03-02+ | INKT | Holcomb John Bradley | Dir | A - Grant | $11.59 | +2,330 | 3,458 | +207% | +$27.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | A | A | 1,239 | $10.90 | 2,367 | D | — | — | (F2) Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely. |
| 2 | Common | Common Stock | 2026-06-01 | A | A | 1,091 | $12.38 | 3,458 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. |